| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0db0591a26743dd86a60ca50a6bcfa93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6774d64d8418a81f2d538355d96a31b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b37299d88f916e078b0917579a92921d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bfda4f734c03a8aa8fded1eebfb985c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-02 |
| filingDate |
2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac439adb3c6829900df9c3600a578dd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be2266c95868cb9085ec2d5c988408d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed3662f06c630f2b3376da45a25b351 |
| publicationDate |
2013-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8580833-B2 |
| titleOfInvention |
Substituted imidazole derivatives and methods of use thereof |
| abstract |
The present invention provides imidazole derivatives of Formula (I) and pharmaceutically acceptable salts thereof. n nThese compounds are useful in the treatment of RAGE-mediated diseases such as Alzheimer's Disease.n n The present invention further relates to methods for the preparation of compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds, and the use the such compounds and/or pharmaceutical compositions in treating RAGE-mediated diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020076668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3822291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016201368-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9598375-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717710-B2 |
| priorityDate |
2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |